This drug is compounded by a licensed pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act, and may be dispensed only pursuant to a patient-specific prescription issued by a licensed practitioner following a medical evaluation. The FDA does not review or approve compounded medications, including Tirzepatide+, for safety, effectiveness, or quality. Compounded tirzepatide has not been approved by the FDA for weight loss, though third-party research studies suggest potential benefits. Individual results may vary, This compounded formulation of tirzepatide is not affiliated with, endorsed or approved by, or intended to replace the FDA-approved products manufactured by Eli Lilly. Actual product packaging may appear differently than shown here.